Infection and chemotherapy

The Korean Society of Infectious Diseases (대한감염학회)
권호 표지
DOI QR코드

DOI QR Code

Treatment of Severe Pandemic Influenza A/H1N1 Infection

중증 신종인플루엔자의 치료

Kim, Sung-Han
김성한

  • Published : 20091000
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Dwyer D. Mini-lecture In Slide session on Novel H1N1 influenza: late-breakers. In: Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA. American Society for Microbiology, 2009
  2. Department of Health, UK. Swine flu-UK planning assumptions. [cited 2009 Oct 21] Available from: URL:http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_104844
  3. Zilberberg MD, Sandrock C, Shorr A. Swine origin influenza A (H1N1) virus and ICU capacity in the US: Are we prepated? PLoS Currents Influenza 22: RRN1009, 2009
  4. Sweet M. Pandemic lessons from Australia. Brit Med J 339:b3317, 2009 https://doi.org/10.1136/bmj.b3317
  5. Flahault A. First estimation of direct H1N1pdm virulence: From reported non consolidated data from Mauritius and New Caledonia. PLoS Currents Influenza RRN1010, 2009
  6. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, Marques A, Guerrero J, Ruiz-Santana S, Marquez E, Del Nogal-Saez F, Alvarez-Lerma F, Martinez S, Ferrer M, Avellanas M, Granada R, Maravi-Poma E, Albert P, Sierra R, Vidaur L, Ortiz P, Prieto Del Portillo I, Galvan B, Leon-Gil C; the H1N1 SEMICYUC working group. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care 13:R148, 2009 (Epub ahead of print on Sep 11 2009) https://doi.org/10.1186/cc8044
  7. Vaillant L, La Ruche G, Tarantola A, Barboza P; epidemic intelligence team at InVS. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill 14:pii:19309, 2009
  8. Wilson N, Baker MG. The emerging influenza pandemic: estimating the case fatality ratio. Euro Surveill 14:pii:19255, 2009
  9. Miller MA, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics-implications for policy. N Engl J Med 360;2595-8, 2009 https://doi.org/10.1056/NEJMp0903906
  10. Nishiura H, Klinkenberg D, Roberts M, Heesterbeek JA. Early epidemiological assessment of the virulence of emerging infectious diseases: a case study of an influenza pandemic. PLoS One 4:e6852, 2009 https://doi.org/10.1371/journal.pone.0006852
  11. Ruiz-Palacios GM. Ground zero: the emgergence of a pandemic? In Symphosium on Influenza: experiencing the unexpected. In: Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA. American Society for Microbiology, 2009
  12. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, Devos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus. N Engl J Med 2009 (Epub ahead of print on Sept 10 2009)
  13. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, Sakabe S, Imai M, Hatta Y, Watanabe S, Li C, Yamada S, Fujii K, Murakami S, Imai H, Kakugawa S, Ito M, Takano R, Iwatsuki-Horimoto K, Shimojima M, Horimoto T, Goto H, Takahashi K, Makino A, Ishigaki H, Nakayama M, Okamatsu M, Takahashi K, Warshauer D, Shult PA, Saito R, Suzuki H, Furuta Y, Yamashita M, Mitamura K, Nakano K, Nakamura M, Brockman-Schneider R, Mitamura H, Yamazaki M, Sugaya N, Suresh M, Ozawa M, Neumann G, Gern J, Kida H, Ogasawara K, Kawaoka Y. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021-5, 2009焈돀㣹?⨀塨?⨀?⨀䤈돐ࠨ?⨀?잖⨀ဨ?⨀℈덐
?⨀ 萁︀䤆䭓䍉〹ٔ䥟䥄堮蠁︀⸁ĀĢ萁︀∆䭓䍉〹͒䕆Т呉∈噁剃䡁刲￿！老耀 https://doi.org/10.1038/nature08260
  14. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931-9, 2009 https://doi.org/10.1038/nature08157
  15. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, Cox NJ, Katz JM, Taubenberger JK, Palese P, García-Sastre A. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310:77-80, 2005 https://doi.org/10.1126/science.1119392
  16. Mcculiers JA. Influenza and bacteria: a lethal syngergism? In Symphosium on Influenza: experiencing the unexpected. In: Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA. American Society for Microbiology, 2009
  17. Morens DM, Taubenberger JK. Understanding influenza backward. JAMA 302:679-80, 2009 https://doi.org/10.1001/jama.2009.1127
  18. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, Gustin KM, Pearce MB, Viswanathan K, Shriver ZH, Raman R, Cox NJ, Sasisekharan R, Katz JM, Tumpey TM. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325:484-7, 2009 https://doi.org/10.1126/science.1177238
  19. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, van de Vijver D, Boucher CA, Koopmans M, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325;481-3, 2009 https://doi.org/10.1126/science.1177127
  20. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, Higuera A, Mondragon E, Cordova-Villalobos JA; INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 361-680-9, 2009 https://doi.org/10.1056/NEJMoa0904252
  21. Oughton MT, Dascal A, Laporta D, Charest H, Afilalo M, Miller MA. Evidence of viremia in two cases of severe pandemic influenza A H1N1/09. Late-breaker poster session (V-1074i). In: Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: American Society for Microbiology, 2009.
  22. Johnson KK, Faden H, Joshi P, Fasanello JF, Hernan LJ, Fuhrman BP, Welliver RC, Sharp JK, Schentag JJ. Two fatal pediatric cases of pandemic H1N1/09 influenza complicated by community-acquired methicillinresistant Staphylococcus aureus. Late-breaker poster session (G1-1558a). In: Program and abstracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA. American Society for Microbiology, 2009
  23. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus, Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S, Uyeki TM. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 358:261-73, 2008 https://doi.org/10.1056/NEJMra0707279
  24. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan, June 2009. MMWR Morb Mortal Wkly Rep 58:749-52, 2009
  25. Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Lui GC, Wong BC, Wong RY, Lam WY, Chu IM, Lai RW, Cockram CS, Sung JJ. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 200:492-500, 2009 https://doi.org/10.1086/600383
  26. Smee DF, Hurst BL, Wong MH, Bailey KW, Morrey JD. Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob Agents Chemother 53:2120-8, 2009 https://doi.org/10.1128/AAC.01012-08
  27. Nguyen JT, Hoopes JD, Smee DF, Prichard MN, Driebe EM, Engelthaler DM, Le MH, Keim PS, Spence RP, Went GT. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob Agents Chemother 53:4115-26, 2009 https://doi.org/10.1128/AAC.00476-09
  28. Nguyen JT, Hoopers J, Smee D, Le M, Patick A, Dejong M, Went G, Faix D, Blair P, Prichard M. In vitro synergy of antiviral combinations against novel influenza A/H1N1 virus. Late-breaker slide session (V-537a). In: Program and absctracts of the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA. American Society for Microbiology, 2009
  29. Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 26 Suppl 4:D59-66, 2008 https://doi.org/10.1016/j.vaccine.2008.07.025
  30. Centers for Disease Control and Prevention (CDC). Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection-Unites States, April-August 2009. MMWR 58:941-5, 2009
  31. Barlow GD; on behalf of the BSAC Council. Swine flu and antibiotics. J Antimicrob Chemother 64:889-94, 2009 https://doi.org/10.1093/jac/dkp313
  32. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, Long HT, Hien NT, Mai le Q, Taylor WR, Wertheim H, Farrar J, Khang DD, Horby P. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 48:1639-46, 2009 https://doi.org/10.1086/599031
  33. Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med 145:599-609, 2006 https://doi.org/10.7326/0003-4819-145-8-200610170-00139
  34. Simmons CP, Bernasconi NL, Suguitan AL, Mills K, Ward JM, Chau NV, Hien TT, Sallusto F, Ha do Q, Farrar J, de Jong MD, Lanzavecchia A, Subbarao K. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med 4:e178, 2007 https://doi.org/10.1371/journal.pmed.0040178
  35. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357:1450-1, 2007 https://doi.org/10.1056/NEJMc070359
  36. HK researchers propose harvesting convalescent plasma to fight new flu. [cited 2009 Oct 21]. Available from:URL:http://news.xinhuanet.com/english/2009-08/26/content_11948637.htm
  37. Department of Health & Human Services, Centers for Disease Control. Community Strategy for Pandemic Influenza Mitigation. [cited 2009 Oct 21]. Available from:URL:http://www.flu.gov/professional/community/commitigation.html

Cited by

  1. 신종 인플루엔자 A (H1N1) 감염으로 입원한 성인 폐렴 환자의 임상양상 vol.69, pp.1, 2009, https://doi.org/10.4046/trd.2010.69.1.24
  2. Two Cases of Respiratory Distress Syndrome Caused by Hospital-Acquired Pandemic Influenza (H1N1 2009) in Kidney Transplant Recipients vol.42, pp.2, 2010, https://doi.org/10.3947/ic.2010.42.2.117
  3. A Fetal Case of Pandemic Influenza (H1N1 2009) by the Aggravated Heart Faiure vol.42, pp.2, 2010, https://doi.org/10.3947/ic.2010.42.2.132
  4. Corticosteroid Treatment in Critically Ill Patients with Pandemic Influenza A/H1N1 2009 Infection : Analytic Strategy Using Propensity Scores vol.183, pp.9, 2009, https://doi.org/10.1164/rccm.201101-0110oc
  5. Clinical Features of Hospitalized Patients with Community Acquired Pneumonia during 2009 Influenza A (H1N1) Pandemic vol.26, pp.3, 2009, https://doi.org/10.4266/kjccm.2011.26.3.162
  6. Clinical and Laboratory Finding of the 2009 Pandemic influenza A (H1N1) in Children vol.18, pp.2, 2011, https://doi.org/10.14776/kjpid.2011.18.2.173